Immediate Impact
7 from Science/Nature 68 standout
Citing Papers
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
2024 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Biao Xing being referenced
Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy.
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Biao Xing | 113 | 96 | 72 | 32 | 389 | |
| Zenan Wang | 98 | 52 | 41 | 44 | 407 | |
| Soo-Young Lee | 125 | 78 | 34 | 26 | 399 | |
| Jin Liu | 182 | 22 | 31 | 79 | 449 | |
| Tongtong Li | 64 | 17 | 23 | 30 | 407 | |
| Akihiro Kanno | 153 | 40 | 71 | 46 | 425 | |
| Xin Wei | 93 | 29 | 42 | 30 | 400 | |
| Zhaolun Li | 170 | 74 | 18 | 33 | 453 | |
| T. Kobayashi | 109 | 90 | 39 | 27 | 434 | |
| Yu‐Hsiu Lee | 94 | 48 | 37 | 26 | 403 | |
| Wensheng Qiu | 240 | 107 | 53 | 40 | 458 |
All Works
Loading papers...